|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date27 Mar 1992 |
|
MechanismTubulin inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
随机、双盲、与阳性药物平行对照评价氟比洛芬酯注射液治疗术后疼痛的安全性及有效性的多中心临床研究
[Translation] A randomized, double-blind, multicenter clinical study on the safety and efficacy of flurbiprofen axetil injection in the treatment of postoperative pain
与阳性药物相比较,评价氟比洛芬酯注射液治疗术后疼痛患者的安全性及有效性
[Translation] To evaluate the safety and efficacy of flurbiprofen axetil injection in the treatment of postoperative pain patients compared with positive drugs
评估右酮洛芬氨丁三醇注射液在中国健康受试者中的药代动力学研究—— 一项单中心、随机、开放的I期临床研究
[Translation] A study to evaluate the pharmacokinetics of dexketoprofen tromethamine injection in Chinese healthy subjects - a single-center, randomized, open-label phase I clinical study
主要目的:评估右酮洛芬氨丁三醇注射液在中国健康受试者中单、多次给药后的药代动力学特征。
次要目的:评估右酮洛芬氨丁三醇注射液在中国健康受试者中单、多次给药后的安全性。
[Translation] Main purpose: To evaluate the pharmacokinetic characteristics of dexketoprofen tromethamine injection in Chinese healthy subjects after single and multiple doses.
Secondary purpose: To evaluate the safety of dexketoprofen tromethamine injection in Chinese healthy subjects after single and multiple doses.
注射用伏立康唑在健康受试者中的耐受性评价和药代动力学比较研究
[Translation] Tolerability evaluation and pharmacokinetic comparison of voriconazole for injection in healthy subjects
主要目的: 1.比较单次/多次静脉输注受试制剂或参比制剂注射用伏立康唑后中国健康受试者的安全性和耐受性。
2.考察受试制剂和参比制剂的主要药代动力学参数是否满足生物等效。
次要目的:比较单次/多次静脉输注受试制剂或参比制剂注射用伏立康唑后的药代动力学特征。
[Translation] Main objectives: 1. To compare the safety and tolerability of Chinese healthy subjects after single/multiple intravenous infusion of test preparation or reference preparation voriconazole for injection.
2. Check whether the main pharmacokinetic parameters of the test preparation and the reference preparation meet the bioequivalence.
Secondary objective: To compare the pharmacokinetics of voriconazole for injection after single/multiple intravenous infusions of the test preparation or the reference preparation.
100 Clinical Results associated with Shanxi Pude Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Shanxi Pude Pharmaceutical Co., Ltd.
100 Deals associated with Shanxi Pude Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Shanxi Pude Pharmaceutical Co., Ltd.